Navigation Links
Bayer CropScience Announces Investment of $25 Million for Institute Site
Date:8/26/2009

INSTITUTE, W.Va., Aug. 26 /PRNewswire/ -- Bayer CropScience today announced an investment of $25 million for further enhancing operational safety at its Institute, W.Va. site. As part of these plans, the company will reduce methyl isocyanate (MIC) storage by 80 percent. This reduction will lead to the elimination of the transfer, use and storage of MIC at the site's West Carbamoylation Center within approximately one year. After completion of these measures, there will be no MIC storage above ground anywhere on the site.

Bayer CropScience President & CEO Bill Buckner said, "While MIC was not involved in the explosion at the Institute site in August last year, we have taken seriously the concerns of public officials and the site's neighbors, and we are making very substantial changes in how we operate our facility in the future."

A number of changes have already been implemented, including the hiring of an emergency services leader to interact with public emergency responders and new procedures, including dedicated phone lines and back-up radios, for communicating with Metro 911. Buckner added that the site also had participated recently in a successful emergency drill with the Kanawha Putnam Emergency Planning Committee.

"Within approximately one year we also will cease production of all MIC-based products currently manufactured in the West Carbamoylation Center," Buckner stated. As part of this, the company will not reconstruct the methomyl facility. To offset changes in Bayer CropScience's production, the industrial park will seek new tenants so to maintain a substantial business presence in the Kanawha Valley. Company officials said today they will work with state and federal officials to attract new businesses to the 465-acre site.

The company aims at implementing these changes to the site's production with the least amount of impact on the em
'/>"/>

SOURCE Bayer CropScience AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Bayer CropSciences Vegetable Seed Business Nunhems Acquires US Lettuce Seed Company Paragon Seed
2. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
3. Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R)
4. Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement
5. Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx
6. Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
7. Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period
8. Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting
9. CTI Enters Into Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data for Potential U.S. Supplemental Marketing Application
10. Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience
11. Bayer Broadens Its Manufacturing Basis for Biopharmaceuticals in Tobacco Plants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... South Korea , March 4, 2015 ... biopesticide company, in August of last year. As part ... Kyung Bon Koo continuing his role as ... , President of Vegalab S.A., will work alongside Koo ... Photo - http://photos.prnewswire.com/prnh/20150303/179218 ...
(Date:3/4/2015)... March 4, 2015 ... Paris en décembre 2011, l,étude ...   », qui compare   l es ...   sorafénib dans le carcinome hépatocellulaire avancé, a ... du foie avancé   ; les résultats sont ...
(Date:3/3/2015)... DIEGO , March 3, 2015  Halozyme Therapeutics, Inc. ... Barclays 2015 Global Healthcare Conference in Miami, FL ... a.m. PT. David A. Ramsay , Chief Financial Officer, ... be webcast through the "Investors" section of Halozyme,s corporate website ... available for 90 days following the event. To access the ...
(Date:3/3/2015)... ON , March 3, 2015 /PRNewswire/ - BIOREM Inc. (TSXV: ... $3.7 million.  The orders are for odour control projects in ... and Asia . "Bidding activity ... , President and CEO. "After a high volume year for bidding ... into the New Year.  The recent orders reflect the organization,s renewed ...
Breaking Biology Technology:Korean Government Program Supports Vegalab's Research and Development 2Korean Government Program Supports Vegalab's Research and Development 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6Halozyme Therapeutics To Present At The Barclays 2015 Global Healthcare Conference 2
... is crucial to preventing countless human diseases. In a ... discovered a new approach for studying molecules within their ... of how bacteria infect people. The research, led ... published in the Proceedings of the National Academy ...
... American Ceramic Society (ACerS) today announced the names of ... B. Marshall and Koichi Niihari are the 2011 recipients ... accorded members of ACerS. The award is given in ... and glass profession. "The Society,s Distinguished Life Member ...
... China Cord Blood Corporation (NYSE: CO ) ("CCBC" ... laboratory testing, hematopoietic stem cell processing, and stem cell storage ... first quarter of fiscal year 2012, which ended June 30, ... of Fiscal 2012Highlights Revenue ...
Cached Biology Technology:Scientists develop new technologies for understanding bacterial infections 2Scientists develop new technologies for understanding bacterial infections 3The American Ceramic Society selects Marshall, Niihara as 2011 Distinguish Life Members 2China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 2China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 3China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 4China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 5China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 6China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 7China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 8China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 9China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2012 10
(Date:2/18/2015)... , Feb. 18, 2015  Cepheid (NASDAQ: CPHD ... the following conferences, and invited investors to participate via webcast. ... Boston, MA Tuesday, March 3, 2015 at 11.20 ... Orlando, FL Wednesday, March 4, 2015 ... To access the live webcasts for these events, please visit ...
(Date:2/11/2015)... DALLAS , February 11, 2015 /PRNewswire/ ... market research report "Access Control Market by Product ... (Commercial, Residential, Military and Defense, Government, Industrial, Healthcare, ... , published by MarketsandMarkets, the Access Control ... by 2020, growing at a CAGR of ...
(Date:2/5/2015)... Feb. 5, 2015  Marken is starting its 35 ... has launched a new marketing campaign to solidify its ... The new campaign focuses on First as ... shipments. The first headline in the series, ... priorities with its client,s priorities. Marken recognizes the need ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... TORONTO, ON Psychologists at the University of ... interaction has the ability to influence an individual,s sensitivity ... clinical implications for doctor-patient relationships and the general well-being ... of studies over the past several decades have demonstrated ...
... CHICAGO --- Northwestern Medicine researchers at the Robert H. ... a new, nontoxic drug made from a chemical in soy ... to the rest of the body. These findings will ... Research Frontiers in Cancer Prevention Research Conference. Genistein, a ...
... at the University of California, San Diego School of ... of federally approved drugs to more than 1,000 proteins ... opening new avenues to repurpose these drugs to treat ... PLoS Computational Biology . "Tuberculosis is currently ...
Cached Biology News:Psychologists identify influence of social interaction on sensitivity to physical pain 2Soy may stop prostate cancer spread 2TB-drugome provides new targets for anti-tuberculosis drug discovery 2
... The BioGenex VISION Sytem is ... that comes with proprietary digital imaging ... for digital image acquisition, analysis, archving/retrieval ... is a state-of-the-art digital imaging system ...
... -mr agarose is specifically for ... endoosmosis, and is recommended for ... weight proteins or complexes that ... of molecular sieving in polyacrylamide ...
... is used for second-dimension SDS-PAGE sample ... place in PROTEAN Plus cells. Bromophenol ... allow monitoring of electrophoresis runs. The ... in 1x Tris, glycine, SDS, and ...
The Trans-Blot Plus gel and cassette assembly tray is used to hold the Trans-Blot Plus gel holder cassette, buffer, and other materials for the gel and membrane sandwich during their assembly....
Biology Products: